eComment. Cardiac resynchronization therapy in cardiac surgery
نویسندگان
چکیده
منابع مشابه
Cardiac-resynchronization therapy.
Cardiac resynchronization therapy (CRT) addresses abnormal left ventricular (LV) activation that produces detrimental effects on cardiac systolic and diastolic function. CRT improves symptoms and ventricular performance, promotes reverse remodeling, and decreases mortality and hospitalization in patients with congestive heart failure (CHF). Atrial-synchronized biventricular stimulation reverses...
متن کاملCardiac Resynchronization Therapy
According to the 2013 update on heart disease statistics from American Heart Association, an estimated 5.1 million Americans ≥20 years of age have a diagnosis of heart failure. In the year 2009, heart failure was noted to be the primary cause of death in >56 000 people and contributed to death of >274 000 people. It is one of the most common causes of hospitalization in patients ≥65 years of ag...
متن کامل[Cardiac resynchronization therapy].
Fifteen years after the birth of resynchronization therapy, this technique has become one of the recommended treatments in severe heart failure patients, with low ejection fraction (4 35%), and conduction disorders (ORS > or = 120 ms). Based on large randomized clinical trials, the European recommendation is class I type (level of evidence A), to improve symptoms and survival of this patient po...
متن کاملCardiac Resynchronization Therapy
Cardiac Resynchronization Therapy. Cardiac resynchronization therapy (CRT) is a recently developed approach to treat dilated heart failure with discoordinate contraction. Such dyssynchrony typically stems from electrical delay that then translates into mechanical delay between the septal and lateral walls. Over the past decade, many studies have examined the pathophysiology of cardiac dyssynchr...
متن کاملCardiac resynchronization therapy.
Systolic heart failure is a major problem for Americans today, with 550,000 new cases diagnosed per year, and ultimately contributes to 287,000 deaths annually. While pharmacologic therapy has drastically improved outcomes in patients with systolic heart failure, hospitalizations from systolic heart failure continue to increase and remain a major cost burden. In response to this unmet need, rec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Interactive CardioVascular and Thoracic Surgery
سال: 2012
ISSN: 1569-9293,1569-9285
DOI: 10.1093/icvts/ivs407